At what enterprise value was INULA GROUP acquired in 2018?

During the acquisition of INULA GROUP by ARDIAN in 2018, the transaction's Enterprise Value is estimated to be in the range of 500M - 1.5b EUR.

What was the EV/EBITDA of INULA GROUP when it was acquired by ARDIAN?

The estimated EV/EBITDA multiple for INULA GROUP is in the range of 15x - 25x.

When was INULA GROUP acquired by ARDIAN?

INULA GROUP was acquired by ARDIAN in 2018.

What was the revenue of INULA GROUP at the time of the deal?

The revenue of INULA GROUP at the time of the deal is estimated to be in the range of 50M - 100M EUR.

What was the EBITDA of INULA GROUP during the acquisition?

INULA GROUP's EBITDA is estimated to be in the range of 25M - 50M EUR.

How is the data for the INULA GROUP acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the INULA GROUP deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.ardian.com/fr/communiques-de-presse/ardian-signe-un-accord-en-vue-dacquerir-le-group-inula-leader-europeen-des

What is the average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026?

The average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026 is 14.3x.

← DATABASE

Home Database Healthcare & PharmaINULA GROUP

10/2018

INULA GROUP acquired by ARDIAN

BELGIUM Life Sciences / Pharma & Biotech EV 500M - 1.5b EUR

Context

Ardian acquired a majority stake in Inula from Vendis Capital and founder Dominique Baudoux. The founder and Vendis Capital retained reinvestment options, while the CEO and the management team reinvested significantly to increase their equity stake. The acquisition aimed to leverage Ardian's global footprint to accelerate Inula's expansion in the US, Italy, and Germany, and to pursue buy-and-build opportunities in the fragmented aromatherapy market.

INULA GROUP, which reported an EBITDA margin of in 2017, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (14.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Inula is a leading Belgian group specializing in natural therapies and phytotherapy. It operates through three flagship brands: Pranarom (scientific aromatherapy/essential oils), HerbalGem (concentrated gemmotherapy), and Biofloral (Bach flowers and floral extracts). The group is distinguished by its medical and scientific approach to natural products, sold primarily through pharmacies and organic specialty stores.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2017

2016

Similar deals in Life Sciences

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
12/2018	MERCK & CO.	ANTELLIQ	FRANCE	Animal Health
11/2018	ARDIAN	NEOPHARMED GENTILI	ITALY	Generics / Labs
10/2018	ASTORG	NEMERA	FRANCE	Medical Consumables
10/2018	BRIDGEPOINT	HTL BIOTECHNOLOGY	FRANCE	CDMO
10/2018	GLANBIA	SLIMFAST	UNITED STATES	Nutrition & Dietary Supplements
08/2018	DENTRESSANGLE	ACTEON	FRANCE	Medical Devices
05/2018	NN	PARAGON MEDICAL	UNITED STATES	Medical Devices
05/2018	Zoetis	Abaxis	UNITED STATES	Diagnostic Equipment
05/2018	PERMIRA	CORIN GROUP	UNITED KINGDOM	Implants & Prosthetics
12/2017	PERKINELMER	EUROIMMUN MEDICAL LABORATORY DIAGNOSTICS	GERMANY	Diagnostic Equipment

REFERENCES

Valuation range: EV 500M - 1.5b EUR

Revenue range: 50M - 100M EUR

EBITDA range: 25M - 50M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of INULA GROUP by ARDIAN are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Press release: view release

Target: inula group

Acquirer: ardian